From Startup Precision Biosciences
DURHAM, North Carolina, USA, November 15, 2018 – Precision BioSciences announced today that it has been recognized as the recipient of the 2018 Southeast BIO (SEBIO) Venture Funding Award. Abid Ansari, Precision’s head of finance and operations, accepted the award at the SEBIO Investor and Partnering Forum in Atlanta, Georgia. SEBIO is a non-profit organization that supports innovation and entrepreneurship through events and other resources for emerging companies in the biotech and pharma space.
Precision BioSciences has raised over $270M through partnerships and private financing rounds, including a Series B financing of $110M announced in June of 2018. The size of this round and quality of investors were factors in deciding the award, as well as Precision’s promising ARCUS genome editing technology with its novel approach and wide-ranging potential impact. Precision’s Series B financing was led by ArrowMark Partners and included Franklin Templeton Investments, Cowen Healthcare Investments, Brace Pharma Capital, Pontifax AgTech, OCV Partners, Adage Capital Management, Cormorant Asset Management, Gilead Sciences, Vivo Capital, Alexandria Venture Investments, Ridgeback Capital, Agent Capital, and entities affiliated with Leerink Partners. Previous investors venBio, F-Prime, RA Capital Management, Amgen Ventures, Osage University Partners, DUMAC, and the Longevity Fund also participated in the Series B financing.
Accepting the award, Ansari expressed his gratitude for this recognition and for the important role that SEBIO plays in supporting the life science industry in and around Precision’s rapidly growing main campus in Durham, North Carolina.
About Precision BioSciences
Precision BioSciences is dedicated to improving life. Our mission is to cure genetic disease, overcome cancer, and feed the planet. We are striving to achieve this goal with ARCUS, our therapeutic-grade, naturally-derived genome editing system that combines both specificity and efficacy to help overcome life’s greatest genetic challenges. For additional information, please visit www.precisionbiosciences.com. For additional information, please visit www.precisionbiosciences.com.
Please visit their site for more information: Precision Biosciences.com
All,Biotechnology,Healthcare News,Startup News